Enovis Corp
NYSE:ENOV

Watchlist Manager
Enovis Corp Logo
Enovis Corp
NYSE:ENOV
Watchlist
Price: 35.3 USD 2.02% Market Closed
Market Cap: 2B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one ENOV stock under the Base Case scenario is 92.27 USD. Compared to the current market price of 35.3 USD, Enovis Corp is Undervalued by 62%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ENOV Relative Value
Base Case
92.27 USD
Undervaluation 62%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.9
P/S
P/S
Price to Sales
0.9
vs History
68
vs Industry
63
Median 3Y
1.8
Median 5Y
1.5
Industry
2.2
Forward
0.9
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-25.1
Median 5Y
-33.7
Industry
21.9
Forward
10.6
More Details
17.4
P/OCF
P/OCF
Price to OCF
17.4
vs History
44
vs Industry
20
Median 3Y
24.1
Median 5Y
14
Industry
13.5
More Details
2.7
P/FCFE
P/FCFE
Price to FCFE
2.7
vs History
42
vs Industry
41
Median 3Y
2.9
Median 5Y
-1.3
Industry
19.3
More Details
0.8
P/B
P/B
Price to Book Value
0.8
vs History
71
vs Industry
67
Median 3Y
0.8
Median 5Y
0.8
Industry
2.1
More Details
1.5
EV/S
EV/S
Enterprise Value to Sales
1.5
vs History
66
vs Industry
53
Median 3Y
2
Median 5Y
1.8
Industry
2.3
Forward
1.4
More Details
2.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.7
vs History
66
vs Industry
59
Median 3Y
3.5
Median 5Y
3.3
Industry
4.8
More Details
10.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
10.9
vs History
61
vs Industry
29
Median 3Y
14.6
Median 5Y
12.8
Industry
11.5
Forward
7.7
More Details
264.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
264.1
vs History
20
vs Industry
1
Median 3Y
185.4
Median 5Y
-100.9
Industry
15.6
Forward
11.3
More Details
28.5
EV/OCF
EV/OCF
Enterprise Value to OCF
28.5
vs History
34
vs Industry
12
Median 3Y
30.1
Median 5Y
17.3
Industry
13.3
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
2
Median 3Y
-36.3
Median 5Y
-55.3
Industry
17.3
More Details
0.7
EV/IC
EV/IC
Enterprise Value to IC
0.7
vs History
50
vs Industry
65
Median 3Y
0.7
Median 5Y
0.7
Industry
1.8
More Details

Multiples Across Competitors

ENOV Competitors Multiples
Enovis Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Enovis Corp
NYSE:ENOV
2B USD 0.9 -2.4 10.9 264.1
US
Abbott Laboratories
NYSE:ABT
230B USD 5.4 17 22.1 31.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.6B USD 21.6 76.2 60.8 73.1
US
Boston Scientific Corp
NYSE:BSX
154.7B USD 8.8 76.1 35.9 49.7
US
Stryker Corp
NYSE:SYK
144.3B USD 6.4 48.2 24.9 30.1
IE
Medtronic PLC
NYSE:MDT
108.9B USD 3.3 25.6 13.7 19.3
DE
Siemens Healthineers AG
XETRA:SHL
53.7B EUR 2.4 27.1 15.6 22.2
US
Becton Dickinson and Co
NYSE:BDX
48.9B USD 2.4 28 12.5 22.5
US
Edwards Lifesciences Corp
NYSE:EW
44.5B USD 8 10.7 24.4 26.8
US
IDEXX Laboratories Inc
NASDAQ:IDXX
38.5B USD 9.9 43.4 30.8 34.4
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
266.3B CNY 7.5 23.9 20.9 20.9

See Also

Summary
ENOV intrinsic value, competitors valuation, and company profile.
DCF Valuation
ENOV stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ENOV stock valuation using valuation multiples.
Wall Street Estimates
ENOV price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ENOV stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 252,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.